ARTICLE
21 September 2018

PTO Director To Drive PTAB Precedent Going Forward

RG
Ropes & Gray LLP

Contributor

Ropes & Gray is a preeminent global law firm with approximately 1,400 lawyers and legal professionals serving clients in major centers of business, finance, technology and government. The firm has offices in New York, Washington, D.C., Boston, Chicago, San Francisco, Silicon Valley, London, Hong Kong, Shanghai, Tokyo and Seoul.
The POP itself will include the Director, the Commissioner for Patents, and the Chief Judge of the PTAB.
United States Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

New SOPs Demystify Internal Practices & Consolidate PTAB Policy Control to Director

The PTAB has substantially revised its Standard Operating Procedures ("SOPs") regarding paneling of matters before the PTAB (SOP1) and precedential and informative decisions (SOP2).

SOP1 largely explains existing internal processes relating to assignment/reassignment of judges in the interests of increasing transparency, predictability, and reliability across the USPTO. More specifically, revised SOP1 explains the procedures for panel assignment and for informing parties regarding panel changes. It also explains the process for designating panels with more than three judges, and notes that such panels should be rare and will only occur with the approval of the Director.(here)

Revised SOP2 is likely to draw the most interests as it creates a Precedential Opinion Panel (POP) that effectively moves the previous PTAB precedent setting power away from the judges to the domain of the agency executives.

While the Director, of course, always had the power to drive PTAB policy, the change in precedent setting procedure does diminish the voice of the judges in this regard. That said, the change is not necessarily a bad thing for the public. First, as I have pointed out previously, arriving at a majority vote of 250+ judges to secure precedent is simply too unwieldy given the increased demand of AIA trials. Second, emphasizing the proper hierarchy and control from an Administrative Procedure Act (APA) perspective is helpful given the recent recent challenge to the PTAB under the Appointments Clause of the Constitution. As can be appreciated from SOP2, a political appointee is clearly running the show.

The POP itself will include the Director, the Commissioner for Patents, and the Chief Judge of the PTAB. The POP is explained as serving two primary functions: 1) it may be convened to rehear matters in pending trials and appeals, for example on issues of exceptional importance; and 2) it may assist the Director in determining whether a decision previously issued by the PTAB should be designated as precedential or informative. It is expected that the POP and the procedures described in revised SOP2 will, in most cases, replace the prior practice of expanded paneling under SOP1, with a process that is more transparent and predictable. It is also expected that revised SOP2 will result in more decisions being designated as precedential. Indeed, I would expect new precedent designed to help Patent Owners given the Director's expressed interest in this regard.

Revised SOP2 includes, among other things:

  • Identification of the circumstances when POP members may delegate their authority, and to whom;
  • Provision of notice to the parties when POP review takes place, as well as the identification of the POP members in a particular case;
  • Explanation of the standards, procedures, and timing for requesting POP review in a pending case on rehearing; and
  • -Revised procedures for designating a decision previously issued by the PTAB as precedential or informative.

Expanded panel practices, while not outlawed altogether are essentially gone. If the PTAB finds itself with conflicting PTAB panel decisions on a given issue, the Director can simply step in an set agency policy as is done with other agencies.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More